PREGNANCY: There are no adequate and well-controlled studies in pregnant women. Aurothioglucose should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.
NURSING MOTHERS: Aurothioglucose has been found in the breast milk of women. Due to the potential for serious adverse reactions in nursing infants, decisions should be made whether to discontinue nursing or to discontinue the drug.
SIDE EFFECTS: The most common adverse reactions to aurothioglucose is dermatitis (skin inflammation), pruritus (itching), stomatitis (inflammation affecting the structures in the mouth such as cheeks, gums, tongue, lips, throat). Aurothoglucose can also suppress the bone marrow leading to abnormally low blood counts, including leukopenia, thrombocytopenia, and anemia. It can also cause kidney damage manifest by protein loss in the urine.
REFERENCE: FDA Prescribing Information
Quick GuideLyme Disease Symptoms, Rash, Treatments
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.